LLY

1,008.91

-3.56%↓

JNJ

245.26

-2.05%↓

ABBV

233.8

+0.06%↑

NVS

162.28

-2.9%↓

MRK

119.83

-2.59%↓

LLY

1,008.91

-3.56%↓

JNJ

245.26

-2.05%↓

ABBV

233.8

+0.06%↑

NVS

162.28

-2.9%↓

MRK

119.83

-2.59%↓

LLY

1,008.91

-3.56%↓

JNJ

245.26

-2.05%↓

ABBV

233.8

+0.06%↑

NVS

162.28

-2.9%↓

MRK

119.83

-2.59%↓

LLY

1,008.91

-3.56%↓

JNJ

245.26

-2.05%↓

ABBV

233.8

+0.06%↑

NVS

162.28

-2.9%↓

MRK

119.83

-2.59%↓

LLY

1,008.91

-3.56%↓

JNJ

245.26

-2.05%↓

ABBV

233.8

+0.06%↑

NVS

162.28

-2.9%↓

MRK

119.83

-2.59%↓

Search

Stevanato Group SpA

Aperta

SettoreSettore sanitario

14.42 -5.19

Panoramica

Variazione del prezzo dell'azione

24h

Corrente

Minimo

14.5

Massimo

15.47

Metriche Chiave

By Trading Economics

Entrata

10M

49M

Vendite

23M

303M

P/E

Media del settore

26.733

108.767

EPS

0.162

Rendimento da dividendi

0.34

Margine di Profitto

16.205

Dipendenti

5,521

EBITDA

10M

73M

Raccomandazioni

By TipRanks

Raccomandazioni

Acquista

Previsioni per 12 mesi

+53.54% upside

Dividendi

By Dow Jones

Rendimento da dividendi

Media del settore

0.34%

2.21%

Utili prossimi

4 mar 2026

Statistiche di mercato

By TradingEconomics

Capitalizzazione di Mercato

-2.4B

4.4B

Apertura precedente

19.61

Chiusura precedente

14.42

Notizie sul Sentiment di mercato

By Acuity

50%

50%

155 / 352 Classifica in Healthcare

Punteggio Tecnico

By Trading Central

Fiducia

Weak Bullish Evidence

Stevanato Group SpA Grafico

Le prestazioni passate non sono un indicatore affidabile dei risultati futuri.

Notizie correlate

2 mar 2026, 23:41 UTC

Discorsi di Mercato
Principali Notizie su Eventi

Nikkei May Decline on Concerns About Energy Prices -- Market Talk

2 mar 2026, 23:37 UTC

Discorsi di Mercato
Principali Notizie su Eventi

Gold Edges Higher Amid Middle East Conflict -- Market Talk

2 mar 2026, 23:26 UTC

Principali Notizie su Eventi

How the Iran Conflict Could Pressure Consumer Staples Companies -- Barrons.com

2 mar 2026, 22:41 UTC

Discorsi di Mercato

Australian Reits Wait on Recovery in Trading Multiples -- Market Talk

2 mar 2026, 22:32 UTC

Discorsi di Mercato

Global Forex and Fixed Income Roundup: Market Talk

2 mar 2026, 22:32 UTC

Discorsi di Mercato

RBA Cautious About Potential for Energy Supply Shocks -- Market Talk

2 mar 2026, 22:21 UTC

Discorsi di Mercato

Port of Tauranga's Upgraded Profit View Still Looks Conservative -- Market Talk

2 mar 2026, 22:11 UTC

Discorsi di Mercato

Global Equities Roundup: Market Talk

2 mar 2026, 22:11 UTC

Discorsi di Mercato

Don't Lose Sight of Bigger Picture With Summerset -- Market Talk

2 mar 2026, 22:10 UTC

Acquisizioni, Fusioni, Takeovers

IAC Is Near Deal to Sell Care.com to Private-Equity Firm -- WSJ

2 mar 2026, 22:06 UTC

Discorsi di Mercato

Channel Infrastructure's Dividend Positively Surprises -- Market Talk

2 mar 2026, 22:00 UTC

Discorsi di Mercato
Utili

Global Forex and Fixed Income Roundup: Market Talk

2 mar 2026, 22:00 UTC

Discorsi di Mercato
Utili

Fashion Retailer Hallenstein Glasson Still a Smart Buy -- Market Talk

2 mar 2026, 21:50 UTC

Discorsi di Mercato
Principali Notizie su Eventi

Energy & Utilities Roundup: Market Talk

2 mar 2026, 21:50 UTC

Discorsi di Mercato
Principali Notizie su Eventi

Basic Materials Roundup: Market Talk

2 mar 2026, 21:50 UTC

Discorsi di Mercato

Health Care Roundup: Market Talk

2 mar 2026, 21:35 UTC

Acquisizioni, Fusioni, Takeovers

AT&T Expects Net Debt-To-Adjusted Ebitda Ratio Will Rise to About 3.2x Following Deal With EchoStar and Decline to About 3x by End of 2026

2 mar 2026, 21:34 UTC

Acquisizioni, Fusioni, Takeovers

AT&T Remains on Track to Achieve Its 2026 and Multi-Yr Fincl Guidance

2 mar 2026, 21:30 UTC

Acquisizioni, Fusioni, Takeovers

Update: AES to Be Taken Private in $33 Billion Deal. Why It's the S&P 500's Worst Stock Today. -- Barrons.com

2 mar 2026, 21:17 UTC

Principali Notizie su Eventi

Bank, Brokerage Stocks Recover Lost Ground After Last Week's Selloff -- Despite Iran Conflict -- Barrons.com

2 mar 2026, 20:44 UTC

Utili

Berkshire Stock Falls 5% as Earnings, Abel Letter Fail to Excite Investors -- Barrons.com

2 mar 2026, 20:43 UTC

Discorsi di Mercato
Principali Notizie su Eventi

Treasury Yields Fall, Dollar Strengthens After Attack on Iran -- Market Talk

2 mar 2026, 20:28 UTC

Utili

Strategy Stock Rises. The World's Largest Bitcoin Holder Doubles Down on Its Crypto Bet. -- Barrons.com

2 mar 2026, 20:25 UTC

Discorsi di Mercato
Principali Notizie su Eventi

U.S. Natural Gas Futures Post Moderate Gains -- Market Talk

2 mar 2026, 20:24 UTC

Utili

Berkshire Stock Falls 5% as Earnings, Abel Letter Fail to Excite Investors -- Barrons.com

2 mar 2026, 20:14 UTC

Acquisizioni, Fusioni, Takeovers

Update: AES to Be Taken Private in $33 Billion Deal. Why It's the S&P 500's Worst Stock Today. -- Barrons.com

2 mar 2026, 20:12 UTC

Principali Notizie su Eventi

Palantir Rises on Mideast Conflict. Why It's Moving Like a Defense Stock. -- Barrons.com

2 mar 2026, 20:08 UTC

Discorsi di Mercato
Principali Notizie su Eventi

Global Forex and Fixed Income Roundup: Market Talk

2 mar 2026, 20:08 UTC

Discorsi di Mercato
Principali Notizie su Eventi

Higher Oil Prices Could Boost Capex in Canada Energy Patch -- Market Talk

2 mar 2026, 20:05 UTC

Discorsi di Mercato
Principali Notizie su Eventi

Oil Rises On U.S.-Middle East Conflict, But Settles Off Highs -- Market Talk

Confronto tra pari

Modifica del prezzo

Stevanato Group SpA Previsione

Obiettivo di Prezzo

By TipRanks

53.54% in crescita

Previsioni per 12 mesi

Media 23.83 USD  53.54%

Alto 30 USD

Basso 17.5 USD

Basato su 3 analisti di Wall Street che offrono Obiettivi di Prezzo a 12 mesi per Stevanato Group SpA - Dist negli ultimi 3 mesi.

Consenso sulla valutazione

By TipRanks

Acquista

3 ratings

1

Acquista

2

Mantieni

0

Vendi

Punteggio Tecnico

By Trading Central

21.56 / 22.61Supporto e resistenza

A breve termine

Weak Bullish Evidence

A termine intermedio

Weak Bearish Evidence

A lungo termine

Bullish Evidence

Sentiment

By Acuity

155 / 352 Classifica in Settore sanitario

Notizie sul Sentiment di mercato

Neutral

Volatilità

Sotto la media

Volume delle notizie (RCV)

Media

Notizie finanziarie

Spese di vendita e di amministrazione

Spese operative

Utile prima delle imposte

Vendite

Costo delle vendite

Utile lordo sulle vendite

Interessi passivi sul debito

EBITDA

Utile operativo

$

Chi Siamo Stevanato Group SpA

Stevanato Group S.p.A. engages in the design, production, and distribution of products and processes to provide integrated solutions for bio-pharma and healthcare industries in Europe, the Middle East, Africa, North America, South America, and the Asia Pacific. The company operates in two segments, Biopharmaceutical and Diagnostic Solutions; and Engineering. Its principal products include containment solutions, drug delivery systems, medical devices, diagnostic, analytical services, visual inspection machines, assembling and packaging machines, and glass forming machines. The company was founded in 1949 and is headquartered in Piombino Dese, Italy. Stevanato Group S.p.A. is a subsidiary of Stevanato Holding S.R.L.
help-icon Live chat